{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T06:44:17Z","timestamp":1695797057264},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Penile squamous cell carcinoma (PSCC) remains a challenging malignancy to treat and there is an urgent need of significant improvements at all levels of medical care. In the current review, we summarized the significant obstacles encountered during management of PSCC and discussed the clinical relevance of novel findings and their potential to address these obstacles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The recent genetic and immunological advances suggest that patients with PSCC can benefit from available targeted therapy and immunotherapy options. Moreover, evidence has accumulated over time suggesting that majority of the patients diagnosed with PSCC suffer from psychosocial problems and impaired rehabilitation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Effective prevention strategies against PSCC are urgently needed especially in developing countries given the limited therapeutic options. About a quarter of patients with metastatic PSCC appear to benefit from available targeted therapies and about half of the patients can be a suitable candidate for immune checkpoint blockade as half of the PSCC cases exhibit PD-L1 expression. Moreover, increased public awareness, healthcare provider education and social support programs may help patients suffering from PSCC coping with the psychosocial burdens of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000431","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:15:07Z","timestamp":1557742507000},"page":"249-254","source":"Crossref","is-referenced-by-count":4,"title":["Treating advanced penile cancer: where do we stand in 2019?"],"prefix":"10.1097","volume":"13","author":[{"given":"Ahmet Murat","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Cheriyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"(10 Suppl)","key":"R1-20230926","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.23743","article-title":"Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003","volume":"113","author":"Hernandez","year":"2008","journal-title":"Cancer"},{"key":"R2-20230926","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20230926","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.31194","article-title":"Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956\u20132015","volume":"142","author":"Hansen","year":"2018","journal-title":"Int J Cancer"},{"key":"R4-20230926","doi-asserted-by":"crossref","first-page":"674.e1","DOI":"10.1016\/j.urolonc.2017.08.009","article-title":"Contemporary survival trends in penile cancer: results from the National Cancer Database","volume":"35","author":"Pham","year":"2017","journal-title":"Urol Oncol"},{"key":"R5-20230926","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0022-5347(17)44281-9","article-title":"Penile cancer: relation of extent of nodal metastasis to survival","volume":"137","author":"Srinivas","year":"1987","journal-title":"J Urol"},{"key":"R6-20230926","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1464-410X.2006.06296.x","article-title":"A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines","volume":"98","author":"Hegarty","year":"2006","journal-title":"BJU Int"},{"key":"R7-20230926","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00345-011-0802-0","article-title":"Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma","volume":"31","author":"Chaux","year":"2013","journal-title":"World J Urol"},{"key":"R8-20230926","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12894-018-0365-0","article-title":"Penile cancer in Maranhao, Northeast Brazil: the highest incidence globally?","volume":"18","author":"Coelho","year":"2018","journal-title":"BMC Urol"},{"key":"R9-20230926","doi-asserted-by":"crossref","first-page":"14.e17-14.e24","DOI":"10.1016\/j.urolonc.2017.09.014","article-title":"Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: a report from the National Cancer Database","volume":"36","author":"Attalla","year":"2018","journal-title":"Urol Oncol"},{"key":"R10-20230926","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bju.14110","article-title":"Racial disparity and survival outcomes between African-American and Caucasian American men with penile cancer","volume":"121","author":"Ritch","year":"2018","journal-title":"BJU Int"},{"key":"R11-20230926","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00365590050509913","article-title":"Etiology of squamous cell carcinoma of the penis","volume":"205","author":"Dillner","year":"2000","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"R12-20230926","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","article-title":"History of circumcision, medical conditions, and sexual activity and risk of penile cancer","volume":"85","author":"Maden","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R13-20230926","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10552-011-9785-9","article-title":"Male circumcision and penile cancer: a systematic review and meta-analysis","volume":"22","author":"Larke","year":"2011","journal-title":"Cancer Causes Control"},{"key":"R14-20230926","first-page":"10","article-title":"Should routine neonatal circumcision be a policy to prevent penile cancer?","volume":"43","author":"Tang","year":"2017","journal-title":"Opinion: No Int Braz J Urol"},{"key":"R15-20230926","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s10461-009-9632-0","article-title":"Acceptability of infant male circumcision as part of HIV prevention and male reproductive health efforts in Gaborone, Botswana, and surrounding areas","volume":"14","author":"Plank","year":"2010","journal-title":"AIDS Behav"},{"key":"R16-20230926","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"R17-20230926","first-page":"245","article-title":"A contemporary review of HPV and penile cancer","volume":"30","author":"Stratton","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"R18-20230926","doi-asserted-by":"crossref","first-page":"785","DOI":"10.21037\/tau.2017.05.19","article-title":"Updates on the epidemiology and risk factors for penile cancer","volume":"6","author":"Douglawi","year":"2017","journal-title":"Transl Androl Urol"},{"key":"R19-20230926","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/00365599.2012.677473","article-title":"Initial symptoms and delay in patients with penile carcinoma","volume":"46","author":"Skeppner","year":"2012","journal-title":"Scand J Urol Nephrol"},{"key":"R20-20230926","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/sti.2009.036061","article-title":"Referrals into a dedicated British penile cancer centre and sources of possible delay","volume":"85","author":"Lucky","year":"2009","journal-title":"Sex Transm Infect"},{"key":"R21-20230926","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.juro.2017.01.088","article-title":"Organ sparing surgery for penile cancer: a systematic review","volume":"198","author":"Kamel","year":"2017","journal-title":"J Urol"},{"key":"R22-20230926","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bju.12338","article-title":"Penile cancer: organ-sparing techniques","volume":"114","author":"Hegarty","year":"2014","journal-title":"BJU Int"},{"key":"R23-20230926","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"R25-20230926","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urolonc.2017.09.028","article-title":"Laser ablation as monotherapy for penile squamous cell carcinoma: a multicenter cohort analysis","volume":"36","author":"Tang","year":"2018","journal-title":"Urol Oncol"},{"key":"R26-20230926","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bju.14037","article-title":"Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature","volume":"121","author":"Chipollini","year":"2018","journal-title":"BJU Int"},{"key":"R27-20230926","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-5347(17)41589-8","article-title":"Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results","volume":"140","author":"Catalona","year":"1988","journal-title":"J Urol"},{"key":"R28-20230926","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/bju.13389","article-title":"Dynamic sentinel lymph node biopsy for penile cancer: a comparison between 1- and 2-day protocols","volume":"117","author":"Dimopoulos","year":"2016","journal-title":"BJU Int"},{"key":"R29-20230926","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"R30-20230926","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2017.5608","article-title":"Treatment trends and outcomes for patients with lymph node-positive cancer of the penis","volume":"4","author":"Joshi","year":"2018","journal-title":"JAMA Oncol"},{"key":"R31-20230926","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"R32-20230926","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"R33-20230926","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"R34-20230926","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bju.14013","article-title":"First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"R35-20230926","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.juro.2018.09.056","article-title":"Comparative genomic profiling of refractory and metastatic penile and nonpenile cutaneous squamous cell carcinoma: implications for selection of systemic therapy","volume":"201","author":"Jacob","year":"2019","journal-title":"J Urol"},{"issue":"(3 Pt 1)","key":"R36-20230926","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","article-title":"Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status","volume":"197","author":"Ottenhof","year":"2017","journal-title":"J Urol"},{"issue":"(7 Suppl)","key":"R37-20230926","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1200\/JCO.2019.37.7_suppl.514","article-title":"Penile and uterine cervical squamous cell carcinomas: a comparative genomic profiling study","volume":"37","author":"Jacob","year":"2019","journal-title":"J Clin Oncol"},{"key":"R38-20230926","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clon.2016.12.006","article-title":"The patterns of practice and outcomes of penile cancer in Ontario","volume":"29","author":"Mahmud","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R39-20230926","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-9-8","article-title":"Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer","volume":"9","author":"Maddineni","year":"2009","journal-title":"BMC Urol"},{"key":"R40-20230926","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1097\/NCC.0000000000000366","article-title":"Penis cancer: the lived experience","volume":"40","author":"Gordon","year":"2017","journal-title":"Cancer Nurs"},{"issue":"(Suppl 2)","key":"R41-20230926","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1046\/j.1524-4741.9.s2.13.x","article-title":"The history of breast cancer advocacy","volume":"9","author":"Braun","year":"2003","journal-title":"Breast J"},{"key":"R42-20230926","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejon.2013.06.004","article-title":"The impact of surgical treatment for penile cancer -- patients\u2019 perspectives","volume":"17","author":"Witty","year":"2013","journal-title":"Eur J Oncol Nurs"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:25:23Z","timestamp":1695713123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000431","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}